688617 惠泰医疗
午间休市 04-15 11:29:58
资讯
新帖
简况
每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长
证券之星 · 04-12
每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长
股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息
证券之星 · 04-09
股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息
惠泰医疗：公司预计2026年PFA手术量有较快的增长速度
证券日报 · 04-08
惠泰医疗：公司预计2026年PFA手术量有较快的增长速度
惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%
证券之星 · 04-07
惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%
每周股票复盘：惠泰医疗（688617）2025年营收25.84亿同比增25.08%
证券之星 · 04-05
每周股票复盘：惠泰医疗（688617）2025年营收25.84亿同比增25.08%
每周股票复盘：惠泰医疗（688617）2025年营收25.84亿元同比增长25.08%
证券之星 · 03-29
每周股票复盘：惠泰医疗（688617）2025年营收25.84亿元同比增长25.08%
惠泰医疗(688617)2月28日股东户数0.6万户，较上期增加4.38%
证券之星 · 03-25
惠泰医疗(688617)2月28日股东户数0.6万户，较上期增加4.38%
惠泰医疗(688617.SH)发布2025年度业绩，归母净利润8.21亿元，同比增长21.91%
智通财经 · 03-24
惠泰医疗(688617.SH)发布2025年度业绩，归母净利润8.21亿元，同比增长21.91%
股市必读：3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元
证券之星 · 03-16
股市必读：3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元
每周股票复盘：惠泰医疗（688617）大宗交易机构净卖出1219.39万元
证券之星 · 03-15
每周股票复盘：惠泰医疗（688617）大宗交易机构净卖出1219.39万元
3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元
证券之星 · 03-13
3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元
惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，3月10日股价上涨1.98%
证券之星 · 03-10
惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，3月10日股价上涨1.98%
每周股票复盘：惠泰医疗（688617）回购进展支付1.75亿元
证券之星 · 03-08
每周股票复盘：惠泰医疗（688617）回购进展支付1.75亿元
每周股票复盘：惠泰医疗（688617）2025年净利增21.91%
证券之星 · 03-01
每周股票复盘：惠泰医疗（688617）2025年净利增21.91%
国金证券：给予惠泰医疗买入评级
证券之星 · 02-27
国金证券：给予惠泰医疗买入评级
惠泰医疗发布2025年度业绩快报，盈利8.206亿元
证券之星 · 02-26
惠泰医疗发布2025年度业绩快报，盈利8.206亿元
惠泰医疗：拟以1.5亿至2亿元回购股份用于员工持股计划或股权激励
新京报 · 02-09
惠泰医疗：拟以1.5亿至2亿元回购股份用于员工持股计划或股权激励
每周股票复盘：惠泰医疗（688617）回购股份101.57万股
证券之星 · 02-01
每周股票复盘：惠泰医疗（688617）回购股份101.57万股
惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，1月27日股价上涨2.27%
证券之星 · 01-27
惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，1月27日股价上涨2.27%
每周股票复盘：惠泰医疗（688617）回购进展公布
证券之星 · 01-11
每周股票复盘：惠泰医疗（688617）回购进展公布
加载更多
公司概况
公司名称：
深圳惠泰医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-01-07
主营业务：
深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。
发行价格：
74.46
{"stockData":{"symbol":"688617","market":"SH","secType":"STK","nameCN":"惠泰医疗","latestPrice":259.67,"timestamp":1776223798000,"preClose":257,"halted":0,"volume":461220,"delay":0,"changeRate":0.0104,"floatShares":141000000,"shares":141000000,"eps":6.8641,"marketStatus":"午间休市","change":2.67,"latestTime":"04-15 11:29:58","open":259.17,"high":260.99,"low":255.3,"amount":119000000,"amplitude":0.0221,"askPrice":259.67,"askSize":4,"bidPrice":258.73,"bidSize":4,"shortable":0,"etf":0,"ttmEps":6.8641,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776229200000},"marketStatusCode":3,"adr":0,"adjPreClose":257,"symbolType":"stock_kcb","openAndCloseTimeList":[[1776216600000,1776223800000],[1776229200000,1776236400000]],"highLimit":282.7,"lowLimit":231.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":141041779,"isCdr":false,"pbRate":11.74,"roa":"--","peRate":37.83016,"roe":"28.77%","epsLYR":5.82,"committee":-0.2,"marketValue":36624000000,"turnoverRate":0.0033,"status":0,"floatMarketCap":36624000000},"requestUrl":"/m/hq/s/688617","defaultTab":"news","newsList":[{"id":"2626147124","title":"每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2626147124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626147124?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:13","pubTimestamp":1775927587,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，惠泰医疗报收于260.47元，较上周的255.86元上涨1.8%。本周，惠泰医疗4月9日盘中最高价报264.7元。惠泰医疗当前最新总市值367.37亿元，在医疗器械板块市值排名5/129，在两市A股市值排名563/5196。基于公司业务推进与行业发展状况，公司预计2026年PF手术量有较快的增长速度。公司IBP产品目前处于注册发补阶段，该产品将作为公司心血管介入产品线的重要补充，可进一步完善整体布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626926306","title":"股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2626926306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626926306?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:04","pubTimestamp":1775667856,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，惠泰医疗报收于264.5元，上涨2.81%，换手率0.85%，成交量1.2万手，成交额3.13亿元。当日关注点来自交易信息汇总：4月8日主力资金净流出1059.32万元，游资资金净流入1250.73万元。来自机构调研要点：电生理业务海外布局以欧洲为重点，同步拓展东欧、拉美、亚太及中东市场。来自机构调研要点：公司IBP产品目前处于注册发补阶段，将成为心血管介入产品线的重要补充。公司预计2026年PF手术量将实现较快增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900000971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625944595","title":"惠泰医疗：公司预计2026年PFA手术量有较快的增长速度","url":"https://stock-news.laohu8.com/highlight/detail?id=2625944595","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625944595?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:22","pubTimestamp":1775650920,"startTime":"0","endTime":"0","summary":"证券日报网4月8日讯 ，惠泰医疗在接受调研者提问时表示，基于公司业务推进与行业发展状况，公司预计2026年PFA手术量有较快的增长速度。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-08/doc-inhtuyvv6410178.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-08/doc-inhtuyvv6410178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936167","title":"惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936167?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:15","pubTimestamp":1775553332,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，惠泰医疗报收于257.28元，较前一交易日上涨0.56%，最新总市值为362.84亿元。该股当日开盘256.51元，最高258.28元，最低252.7元，成交额达2.29亿元，换手率为0.64%。公司于近日披露《2025年年度股东会会议资料》。公告显示，深圳惠泰医疗器械股份有限公司2025年度实现营业收入258,392.73万元，同比增长25.08%；归属于母公司股东的净利润82,063.66万元，同比增长21.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625190746","title":"每周股票复盘：惠泰医疗（688617）2025年营收25.84亿同比增25.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625190746","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625190746?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:40","pubTimestamp":1775331623,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，惠泰医疗报收于255.86元，较上周的246.97元上涨3.6%。本周，惠泰医疗4月3日盘中最高价报261.65元。3月30日盘中最低价报243.63元。惠泰医疗当前最新总市值360.84亿元，在医疗器械板块市值排名6/129，在两市A股市值排名540/5193。董事会全年召开8次董事会会议，执行5次股东会决议，各专门委员会履职尽责，独立董事积极参与决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623380798","title":"每周股票复盘：惠泰医疗（688617）2025年营收25.84亿元同比增长25.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623380798","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623380798?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:47","pubTimestamp":1774723627,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，惠泰医疗报收于246.97元，较上周的231.59元上涨6.64%。本周，惠泰医疗3月27日盘中最高价报249.6元。本周关注点来自业绩披露要点：惠泰医疗2025年主营收入25.84亿元，同比上升25.08%。股本股东变化截至2026年2月28日，惠泰医疗股东户数为6030.0户，较2025年12月31日增加253.0户，增幅4.38%。2025年第四季度单季主营收入7.16亿元，同比增长32.44%；单季归母净利润1.97亿元，同比增长36.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622802966","title":"惠泰医疗(688617)2月28日股东户数0.6万户，较上期增加4.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622802966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622802966?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:13","pubTimestamp":1774430005,"startTime":"0","endTime":"0","summary":"证券之星消息，近日惠泰医疗披露，截至2026年2月28日公司股东户数为6030.0户，较12月31日增加253.0户，增幅为4.38%。在医疗器械行业个股中，惠泰医疗股东户数低于行业平均水平，截至2月28日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年2月28日，惠泰医疗区间涨幅为1.22%，在此期间股东户数增加253.0户，增幅为4.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500032123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621060177","title":"惠泰医疗(688617.SH)发布2025年度业绩，归母净利润8.21亿元，同比增长21.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621060177","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621060177?lang=zh_cn&edition=full","pubTime":"2026-03-24 21:23","pubTimestamp":1774358594,"startTime":"0","endTime":"0","summary":"智通财经APP讯，惠泰医疗 发布2025年年度报告，报告期内，公司实现营业收入25.84亿元，同比增长25.08%。实现归属于上市公司股东的净利润8.21亿元，同比增长21.91%。同时，国内电生理传统三维非房颤手术仍在加速推进，报告期内完成手术超1.5万例。报告期内，公司血管介入类产品的覆盖率及入院渗透率进一步提升。报告期末，冠脉产品已进入的医院数量较去年同期增长超13%；外周产品已进入的医院数量较去年同期增长超20%，市场活力表现强劲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"惠泰医疗(688617.SH)发布2025年度业绩，归母净利润8.21亿元，同比增长21.91%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619488399","title":"股市必读：3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619488399","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619488399?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:53","pubTimestamp":1773600788,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，惠泰医疗报收于234.95元，下跌0.27%，换手率0.61%，成交量8613.0手，成交额2.02亿元。交易信息汇总资金流向3月13日主力资金净流入338.6万元，占总成交额1.68%；游资资金净流出253.23万元，占总成交额1.25%；散户资金净流出85.37万元，占总成交额0.42%。大宗交易3月13日惠泰医疗现1笔大宗交易，机构净卖出1219.39万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619117833","title":"每周股票复盘：惠泰医疗（688617）大宗交易机构净卖出1219.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619117833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619117833?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:46","pubTimestamp":1773513970,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，惠泰医疗报收于234.95元，较上周的230.91元上涨1.75%。本周，惠泰医疗3月13日盘中最高价报237.77元。来自公司公告汇总：惠泰医疗完成股份回购，累计回购853,702股，占总股本0.61%。交易信息汇总3月13日惠泰医疗发生1笔大宗交易，机构净卖出1219.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619985971","title":"3月13日惠泰医疗现1笔大宗交易 机构净卖出1219.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619985971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619985971?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:23","pubTimestamp":1773393820,"startTime":"0","endTime":"0","summary":"证券之星消息，3月13日惠泰医疗发生大宗交易，交易数据如下：大宗交易成交价格234.95元，成交5.19万股，成交金额1219.39万元，买方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部，卖方营业部为机构专用。近三个月该股共发生1笔大宗交易，合计成交519.0手。截至2026年3月13日收盘，惠泰医疗报收于234.95元，下跌0.27%，换手率0.61%，成交量8613.0手，成交额2.02亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618491959","title":"惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，3月10日股价上涨1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618491959","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618491959?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:20","pubTimestamp":1773152437,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，惠泰医疗报收于231.5元，较前一交易日上涨1.98%，最新总市值为326.48亿元。近日，惠泰医疗发布《关于股份回购实施结果暨股份变动的公告》。本次回购股份用于员工持股计划或股权激励，资金来源为公司自有资金，不影响公司正常经营及股权分布。回购股份存放于公司回购专用证券账户，未来三年内将用于转让，若未完成转让则依法注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617668012","title":"每周股票复盘：惠泰医疗（688617）回购进展支付1.75亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617668012?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:38","pubTimestamp":1772908691,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，惠泰医疗报收于230.91元，较上周的246.24元下跌6.23%。本周，惠泰医疗3月2日盘中最高价报245.44元。惠泰医疗当前最新总市值325.65亿元，在医疗器械板块市值排名5/129，在两市A股市值排名662/5190。本周关注点公司公告汇总：截至2026年2月28日，公司累计回购股份74.8702万股，已支付金额17,535.15万元。公司公告汇总深圳惠泰医疗器械股份有限公司于2026年2月9日召开董事会，审议通过以集中竞价交易方式回购股份的方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616848046","title":"每周股票复盘：惠泰医疗（688617）2025年净利增21.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616848046","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616848046?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:43","pubTimestamp":1772300593,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，惠泰医疗报收于246.24元，较上周的232.42元上涨5.95%。本周，惠泰医疗2月27日盘中最高价报252.89元。公司公告汇总深圳惠泰医疗器械股份有限公司发布2025年度业绩快报，营业总收入为2,583,927,321.09元，同比增长25.08%；营业利润为943,928,555.84元，同比增长25.24%；归属于母公司所有者的净利润为820,636,582.43元，同比增长21.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614005940","title":"国金证券：给予惠泰医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2614005940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614005940?lang=zh_cn&edition=full","pubTime":"2026-02-27 08:50","pubTimestamp":1772153428,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对惠泰医疗进行研究并发布了研究报告《四季度业绩增长加速，核心产品推广顺利》，给予惠泰医疗买入评级。2025年PFA产品上市后，公司自主举办活动超40场，覆盖行业专家2000+名，并完成国产PFA海外首秀，多次组织海外医生来华观摩进修，进一步扩大PFA国产品牌影响力。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700006955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614019660","title":"惠泰医疗发布2025年度业绩快报，盈利8.206亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614019660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614019660?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:24","pubTimestamp":1772097855,"startTime":"0","endTime":"0","summary":"证券之星消息，惠泰医疗近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利8.206亿元，同比增长21.91%。惠泰医疗（688617）主营业务：公司是一家专注于电生理和血管介入医疗器械的研发、生产和销售的高新技术企业,已形成了以完整冠脉通路和电生理医疗器械为主导,外周血管和神经介入医疗器械为重点发展方向的业务布局。该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610050632","title":"惠泰医疗：拟以1.5亿至2亿元回购股份用于员工持股计划或股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2610050632","media":"新京报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610050632?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:49","pubTimestamp":1770637740,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 2月9日，惠泰医疗公告，公司计划通过集中竞价交易方式回购股份，资金总额不低于1.5亿元，不超过2亿元，用于员工持股计划或股权激励。回购价格不超过315元/股，期限为自董事会审议通过之日起10个月内。公司董事、高级管理人员、控股股东等在未来3个月、6个月无明确的减持计划。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/02/06/5683865291096924542.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/02/06/5683865291096924542.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1770635888129460.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1770635888129460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608077224","title":"每周股票复盘：惠泰医疗（688617）回购股份101.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077224","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077224?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:20","pubTimestamp":1769887223,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，惠泰医疗报收于232.0元，较上周的242.5元下跌4.33%。本周，惠泰医疗1月26日盘中最高价报245.45元。本周关注点公司公告汇总：惠泰医疗回购股份1,015,738股，占总股本0.7202%。公司公告汇总深圳惠泰医疗器械股份有限公司于2025年12月9日至2026年1月28日期间，通过集中竞价交易方式累计回购股份1,015,738股，占公司总股本的0.7202%，回购价格区间为231.00元/股至264.27元/股，支付资金总额24,995.13万元。已回购股份将在三年内按规定转让，若未完成转让将依法注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606801827","title":"惠泰医疗（688617）披露股份回购实施结果暨股份变动公告，1月27日股价上涨2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606801827","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606801827?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:16","pubTimestamp":1769523380,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，惠泰医疗报收于242.6元，较前一交易日上涨2.27%，最新总市值为342.14亿元。近日，惠泰医疗发布《关于股份回购实施结果暨股份变动的公告》。公告显示，公司于2025年12月9日至2026年1月28日期间，通过集中竞价交易方式累计回购股份1,015,738股，占公司总股本的0.7202%，回购价格区间为231.00元/股至264.27元/股，支付资金总额24,995.13万元。已回购股份将在三年内按规定转让，若未完成转让将依法注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602887535","title":"每周股票复盘：惠泰医疗（688617）回购进展公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2602887535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602887535?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:12","pubTimestamp":1768068731,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，惠泰医疗报收于265.66元，较上周的243.27元上涨9.2%。本周，惠泰医疗1月9日盘中最高价报267.57元。惠泰医疗当前最新总市值374.66亿元，在医疗器械板块市值排名5/127，在两市A股市值排名545/5182。本周关注点公司公告汇总：截至2025年12月31日，惠泰医疗已回购股份402,976股，占总股本的0.29%，支付金额9,992.30万元。本次回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776225030457,"stockEarnings":[{"period":"1week","weight":-0.0011},{"period":"1month","weight":0.0938},{"period":"3month","weight":-0.0106},{"period":"6month","weight":-0.1658},{"period":"1year","weight":-0.1328},{"period":"ytd","weight":0.0564}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0241},{"period":"6month","weight":0.0282},{"period":"1year","weight":0.2341},{"period":"ytd","weight":0.0146}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳惠泰医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6030人(较上一季度增加4.38%)","perCapita":"23390股","listingDate":"2021-01-07","address":"广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601","registeredCapital":"14104万元","survey":" 深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。","listedPrice":74.46},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠泰医疗,688617,惠泰医疗股票,惠泰医疗股票老虎,惠泰医疗股票老虎国际,惠泰医疗行情,惠泰医疗股票行情,惠泰医疗股价,惠泰医疗股市,惠泰医疗股票价格,惠泰医疗股票交易,惠泰医疗股票购买,惠泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}